Here we present compelling evidence that insulin resistance at a whole-body level leads to accelerated atherosclerosis and that the complete deletion of Nox2 NADPH oxidase further exacerbates the development of insulin resistance-related atherosclerosis. Here, FMO5 is linked to atherosclerosis.